Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer 2024-02-29 18:09
Hanvon Technology Launches Groundbreaking Fourth-Generation BP Meter Based on Korotkoff Sound Method 2024-02-29 15:13
Chamlion and 3DRPD Forge Collaboration for Dental 3D Production Center 2024-02-29 11:46
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings 2024-02-28 22:03
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS 2024-02-28 20:47
Baird Medical Expands Presence in the United States 2024-02-28 18:00
The promising results of a phase II clinical study for Akeso's Cadonilimab (PD-1/CTLA-4) combined standard treatment for first-line treatment of R/M cervical cancer has been published in Clinical Cancer Research 2024-02-28 17:27
China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split 2024-02-28 05:05
FDA Grants Fast Track Designation to 9MW2821 2024-02-27 22:00
111 Announces Receipt of Withdrawal of Going Private Proposal 2024-02-27 21:58
Origin Agritech Announces Breakthrough in Corn Hybrid Development with Wild Corn Gene Integration 2024-02-27 21:30
Zhongchao Inc. Announces 1-for-10 Share Consolidation 2024-02-27 21:00
Nona Biosciences Enters into Collaboration Agreement with Boostimmune in Antibody-Drug Conjugate Development 2024-02-27 09:23
BioCity Announces Enrollment Completion of the IgA Nephropathy (IgAN) Cohort in the Randomized, Placebo-controlled Phase II Clinical Trial of the ETA Receptor Antagonist SC0062 2024-02-26 22:38
GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj. 2024-02-26 21:30
Aucta Pharmaceuticals, Inc. ("Aucta Pharmaceuticals") launches MOTPOLY XR™ (lacosamide) extended-release capsules C-V, the first, and only once-daily formulation of lacosamide 2024-02-26 21:00
TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor 2024-02-26 21:00
J INTS BIO, Phase 1/2 study of 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, accepted for presentation at the upcoming American Association for Cancer Research 2024 meeting in USA (AACR 2024) 2024-02-26 16:15
Groundbreaking! Phase II Data of LP-003 Unveiled by Longbio Pharma at AAAAI2024 2024-02-26 02:00
China Medical University Hospital's Breakthrough: Leg Salvage Against Deadly Arterial Disease. Amputation and Death Rates Plunge from 30% to Below 3% 2024-02-24 21:30
1 22 23 24 25 26 788